-
Je něco špatně v tomto záznamu ?
A randomized comparison of HBP versus RVP: Effect on left ventricular function and biomarkers of collagen metabolism
J. Mizner, P. Waldauf, D. Grieco, H. Linkova, O. Ionita, P. Vijayaraman, R. Petr, R. Raková, J. Vesela, P. Stros, D. Herman, P. Osmancik, K. Curila
Jazyk angličtina Země Polsko
Typ dokumentu randomizované kontrolované studie, časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2003
Medline Complete (EBSCOhost)
od 2013-04-01
ROAD: Directory of Open Access Scholarly Resources
od 2003
PubMed
36929298
DOI
10.33963/kp.a2023.0065
Knihovny.cz E-zdroje
- MeSH
- biologické markery MeSH
- elektrokardiografie MeSH
- funkce levé komory srdeční * fyziologie MeSH
- Hisův svazek MeSH
- interleukin-1 receptor-like 1 protein MeSH
- kardiomyopatie * MeSH
- kardiostimulace umělá škodlivé účinky MeSH
- kolagen MeSH
- lidé MeSH
- tepový objem fyziologie MeSH
- tkáňový inhibitor metaloproteinasy 1 MeSH
- transformující růstový faktor beta1 MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
BACKGROUND: Right ventricular pacing (RVP) can result in pacing-induced cardiomyopathy (PICM). It is unknown whether specific biomarkers reflect differences between His bundle pacing (HBP) and RVP and predict a decrease in left ventricular function during RVP. AIMS: We aimed to compare the effect of HBP and RVP on the left ventricular ejection fraction (LVEF) and to study how they affect serum markers of collagen metabolism. METHODS: Ninety-two high-risk PICM patients were randomized to HBP or RVP groups. Their clinical characteristics, echocardiography, and serum levels of transforming growth factor β1 (TGF-β1), matrix metalloproteinase 9 (MMP-9), suppression of tumorigenicity 2 interleukin (ST2-IL), tissue inhibitor of metalloproteinase 1 (TIMP-1), and galectin 3 (Gal-3) were studied before pacemaker implantation and six months later. RESULTS: Fifty-three patients were randomized to the HBP group and 39 patients to the RVP group. HBP failed in 10 patients, who crossed over to the RVP group. Patients with RVP had significantly lower LVEF compared to HBP patients after six months of pacing (-5% and -4% in as-treated and intention-to-treat analysis, respectively). Levels of TGF-β1 after 6 months were lower in HBP than RVP patients (mean difference -6 ng/ml; P = 0.009) and preimplant Gal-3 and ST2-IL levels were higher in RVP patients, with a decline in LVEF ≥5% compared to those with a decline of <5% (mean difference 3 ng/ml and 8 ng/ml; P = 0.02 for both groups). CONCLUSION: In high-risk PICM patients, HBP was superior to RVP in providing more physiological ventricular function, as reflected by higher LVEF and lower levels of TGF-β1. In RVP patients, LVEF declined more in those with higher baseline Gal-3 and ST2-IL levels than in those with lower levels.
Department of Cardiology Policlinico Casilino of Rome Rome Italy
Geisinger Heart Institute Wilkes Barre Pennsylvania United States
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010729
- 003
- CZ-PrNML
- 005
- 20230801132614.0
- 007
- ta
- 008
- 230718s2023 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33963/KP.a2023.0065 $2 doi
- 035 __
- $a (PubMed)36929298
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Mizner, Jan $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic. karol.curila@fnkv.cz
- 245 12
- $a A randomized comparison of HBP versus RVP: Effect on left ventricular function and biomarkers of collagen metabolism / $c J. Mizner, P. Waldauf, D. Grieco, H. Linkova, O. Ionita, P. Vijayaraman, R. Petr, R. Raková, J. Vesela, P. Stros, D. Herman, P. Osmancik, K. Curila
- 520 9_
- $a BACKGROUND: Right ventricular pacing (RVP) can result in pacing-induced cardiomyopathy (PICM). It is unknown whether specific biomarkers reflect differences between His bundle pacing (HBP) and RVP and predict a decrease in left ventricular function during RVP. AIMS: We aimed to compare the effect of HBP and RVP on the left ventricular ejection fraction (LVEF) and to study how they affect serum markers of collagen metabolism. METHODS: Ninety-two high-risk PICM patients were randomized to HBP or RVP groups. Their clinical characteristics, echocardiography, and serum levels of transforming growth factor β1 (TGF-β1), matrix metalloproteinase 9 (MMP-9), suppression of tumorigenicity 2 interleukin (ST2-IL), tissue inhibitor of metalloproteinase 1 (TIMP-1), and galectin 3 (Gal-3) were studied before pacemaker implantation and six months later. RESULTS: Fifty-three patients were randomized to the HBP group and 39 patients to the RVP group. HBP failed in 10 patients, who crossed over to the RVP group. Patients with RVP had significantly lower LVEF compared to HBP patients after six months of pacing (-5% and -4% in as-treated and intention-to-treat analysis, respectively). Levels of TGF-β1 after 6 months were lower in HBP than RVP patients (mean difference -6 ng/ml; P = 0.009) and preimplant Gal-3 and ST2-IL levels were higher in RVP patients, with a decline in LVEF ≥5% compared to those with a decline of <5% (mean difference 3 ng/ml and 8 ng/ml; P = 0.02 for both groups). CONCLUSION: In high-risk PICM patients, HBP was superior to RVP in providing more physiological ventricular function, as reflected by higher LVEF and lower levels of TGF-β1. In RVP patients, LVEF declined more in those with higher baseline Gal-3 and ST2-IL levels than in those with lower levels.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a funkce levé komory srdeční $x fyziologie $7 D016277
- 650 _2
- $a tepový objem $x fyziologie $7 D013318
- 650 _2
- $a transformující růstový faktor beta1 $7 D053773
- 650 _2
- $a interleukin-1 receptor-like 1 protein $7 D000072179
- 650 _2
- $a tkáňový inhibitor metaloproteinasy 1 $7 D019715
- 650 _2
- $a kardiostimulace umělá $x škodlivé účinky $7 D002304
- 650 12
- $a kardiomyopatie $7 D009202
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a kolagen $7 D003094
- 650 _2
- $a Hisův svazek $7 D002036
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a elektrokardiografie $7 D004562
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Waldauf, Petr $u Department of Anesthesia and Intensive Care, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Grieco, Domenico $u Department of Cardiology, Policlinico Casilino of Rome, Rome, Italy
- 700 1_
- $a Linkova, Hana $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Ionita, Oana $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Vijayaraman, Pugazhendhi $u Geisinger Heart Institute, Wilkes Barre, Pennsylvania, United States
- 700 1_
- $a Petr, Robert $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Raková, Radka $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Vesela, Jana $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Stros, Petr $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Herman, Dalibor $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Osmancik, Pavel $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Curila, Karol $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 773 0_
- $w MED00003056 $t Kardiologia polska $x 1897-4279 $g Roč. 81, č. 5 (2023), s. 472-481
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36929298 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132611 $b ABA008
- 999 __
- $a ok $b bmc $g 1963275 $s 1196994
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 81 $c 5 $d 472-481 $e 20230316 $i 1897-4279 $m Kardiologia Polska $n Kardiol Pol $x MED00003056
- LZP __
- $a Pubmed-20230718